In 2021, BCC launched their new Precision Medicine Program also termed the In:Formation Project. The program’s vision is that all children with cancer will have complete genomic sequencing and analysis of their tumors at both diagnosis and all relapses. This information CAN help us understand each child and their cancer with the goal of improving outcomes. There are two arms to the BCC In:Formation Project, Clinical and Research. As part of the research arm, when children enroll on the LCI-BCC-BIO-001 Clinical Trial, we combine ALL clinical data, genomic data, outcome data, and lab research data into a database usable by all BCC collaborators to study and analyze this data together.